Skip to main content
Contact Us
Subscribe
E-Edition
64°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Izotropic Corp
(OP:
IZOZF
)
0.0500
+0.0100 (+25.00%)
Streaming Delayed Price
Updated: 1:17 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Izotropic Corp
Izotropic Provides Regulatory and Operational Updates
January 08, 2024
VANCOUVER, BC – TheNewswire - January 8, 2024 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed...
Via
TheNewswire.com
Exposures
Product Safety
Izotropic Announces AGM Results
December 22, 2023
VANCOUVER, BC – TheNewswire - December 22, 2023 – Izotropic Corporation (“Izotropic” or the“Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed...
Via
TheNewswire.com
Izotropic Completes Pre-Submission Meeting With U.S. FDA
November 01, 2023
VANCOUVER, BC, November 1, 2023 – TheNewswire – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed...
Via
TheNewswire.com
Exposures
Product Safety
Izotropic Confirms FDA Pre-Submission Meeting Date
September 27, 2023
Vancouver, BC - TheNewswire - September 27, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed...
Via
TheNewswire.com
Exposures
Product Safety
Izotropic Corporation Announces Non-Brokered Private Placement
September 13, 2023
Vancouver, BC - TheNewswire - September 13, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed...
Via
TheNewswire.com
Izotropic Files Class II Pre-Submission with FDA & Releases Details on Predicate Devices
September 06, 2023
Via
TheNewswire.com
Exposures
Product Safety
Izotropic Engages Market Awareness Consultant
June 27, 2023
VANCOUVER, BC – TheNewswire - JUNE 27, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a 360-degree...
Via
TheNewswire.com
Izotropic Modifies Market Approval Pathway & Strategy
June 20, 2023
VANCOUVER, BC – TheNewswire - JUNE 20, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a 360-degree...
Via
TheNewswire.com
Exposures
Product Safety
Izotropic Completes QSUB Meeting With FDA Regarding Clinical Study Acceleration
May 15, 2023
VANCOUVER, BC – TheNewswire - May 15, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated breast...
Via
TheNewswire.com
Exposures
Product Safety
Izotropic Provides Business Update
April 27, 2023
VANCOUVER, BC – TheNewswire - April 27, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated breast...
Via
TheNewswire.com
Izotropic to Extend Period for Unsecured Loans
March 29, 2023
Vancouver, BC - TheNewswire - March 29, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated breast...
Via
TheNewswire.com
Izotropic's Izoview Breast CT Device to be Featured on Advancements TV Show in USA
January 13, 2023
VANCOUVER, BC – TheNewswire - January 13, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated...
Via
TheNewswire.com
Izotropic Creates Compensation Committee and Adopts Charter
January 12, 2023
Vancouver, BC - TheNewswire - January 12, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated...
Via
TheNewswire.com
Izotropic Releases First Video of IzoView
January 09, 2023
Vancouver, British Columbia--(Newsfile Corp. - January 9, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the...
Via
Newsfile
Izotropic Releases First Video of Izoview
January 09, 2023
VANCOUVER, BC – TheNewswire - January 9, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated...
Via
TheNewswire.com
Izotropic Reports Board Meeting Results
January 04, 2023
VANCOUVER, BC – TheNewswire - January 4, 2023 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated...
Via
TheNewswire.com
Izotropic Delays Announcements to 2023, Holds Board Meeting
December 28, 2022
VANCOUVER, BC – TheNewswire - December 28, 2022 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated...
Via
TheNewswire.com
Izotropic Announces 2022 AGM Results and Clarifies Restating of Financial Statements
December 20, 2022
VANCOUVER, BC – TheNewswire - December 20, 2022 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated...
Via
TheNewswire.com
Izotropic Completes Izoview Development and Assembly, Prepares for Final Testing
December 01, 2022
VANCOUVER, BC – TheNewswire – December 1 , 2022 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated...
Via
TheNewswire.com
Alexander Tokman Joins Izotropic Board Of Directors
November 11, 2022
VANCOUVER, BC – TheNewswire - November 11, 2022 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated...
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
IZOTROPIC CORPORATION Announces Closing of Non-Brokered Private Placement
November 10, 2022
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES
Via
TheNewswire.com
Izotropic Grants Stock Options
November 01, 2022
VANCOUVER, BC – TheNewswire - November 1, 2022 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a dedicated...
Via
TheNewswire.com
Izotropic Implements Quality Management System for IzoView Breast CT Device Manufacturing
November 29, 2021
VANCOUVER, BC - TheNewswire - November 29, 2021 - Izotropic Corporation (“Izotropic” or the “Company”) (CNSX:IZO.CN) (OTC:IZOZF) (FSE:1R3), a Company commercializing a dedicated breast CT (computed...
Via
TheNewswire.com
Topics
Product Recall
Supply Chain
Exposures
Legal
Product Safety
Supply Chain
Izotropic Appoints Medical Device R&D Expert as Executive VP of Product Engineering
June 30, 2021
Vancouver, BC - TheNewswire - June 30, 2021 – Izotropic Corporation (“Izotropic” or the “Company”) (CNSX:IZO.CN) (OTC:IZOZF) (FSE:1R3) a Company commercializing “Izoview,” a true 3D, dedicated Breast...
Via
TheNewswire.com
Topics
Intellectual Property
Exposures
Intellectual Property
Izotropic Appoints Medical Device R&D Expert as Executive VP of Product Engineering
June 30, 2021
Vancouver, British Columbia--(Newsfile Corp. - June 30, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the...
Via
Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
Izotropic Updates Timelines for Clinical Study and Fabrication of Initial Izoview Units
June 03, 2021
Vancouver, British Columbia--(Newsfile Corp. - June 3, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or...
Via
Newsfile
Topics
Supply Chain
Exposures
COVID-19
Product Safety
Supply Chain
Izotropic Updates Timelines for Clinical Study and Fabrication of Initial Izoview Units
June 03, 2021
VANCOUVER, BC - TheNewswire – June 3, 2021 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (CNSX:IZO.CN) (OTC:IZOZF) (FSE:1R3) a Company commercializing “Izoview”, a true 3D, dedicated...
Via
TheNewswire.com
Topics
Supply Chain
Exposures
COVID-19
Product Safety
Supply Chain
Izotropic Provides Corporate Update
May 27, 2021
Vancouver, BC - TheNewswire - May 27, 2021 - Izotropic Corporation (“Izotropic” or the “Company”) (CNSX:IZO.CN) (OTC:IZOZF) (FSE:1R3) is releasing this bulletin to alert and inform shareholders of the...
Via
TheNewswire.com
Exposures
COVID-19
Izotropic Provides Corporate Update
May 27, 2021
Vancouver, British Columbia--(Newsfile Corp. - May 27, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the...
Via
Newsfile
Exposures
COVID-19
Tomosynthesis Pioneer Joins Izotropic Scientific Advisory Board
April 20, 2021
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or...
Via
Newsfile
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.